Pure Global

Clinical Trial - Trial ChiCTR2200055966

Access comprehensive clinical trial information for ChiCTR2200055966 through Pure Global AI's free database. This Phase 2 trial is sponsored by Zhejiang Cancer Hospital and is currently Recruiting. The study focuses on gastric cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200055966
Phase 2
Recruiting
Trial Details
Chinese Clinical Trial Registry โ€ข ChiCTR2200055966
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
A prospective randomized controlled trial of D2 radical resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of advanced gastric cancer

Study Focus

gastric cancer

Sponsor & Location

Zhejiang Cancer Hospital

none

China

Timeline & Enrollment

Phase 2

N/A

Dec 31, 2021

ICD-10 Classifications

Gastric ulcer
Malignant neoplasm of stomach
Malignant neoplasm: Body of stomach
Carcinoma in situ: Stomach
Malignant neoplasm: Stomach, unspecified

Data Source

Chinese Clinical Trial Registry

ChiCTR2200055966

Non-Device Trial